Sionna Therapeutics (SION) Other Non-Current Assets (2024 - 2026)

Sionna Therapeutics has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $585000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $585000.0, down 39.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $585000.0 (down 39.19% YoY), and the FY2025 annual result was $963000.0, down 3.7% from the prior year.
• Other Non-Current Assets came in at $585000.0 for Q1 2026 at Sionna Therapeutics, down from $963000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q4 2024 to a low of $585000.0 in Q1 2026.
• The 3-year median for Other Non-Current Assets is $962000.0 (2024), against an average of $913714.3.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2025 and sank 39.19% in 2026, its largest moves.
• Sionna Therapeutics' Other Non-Current Assets stood at $1.0 million in 2024, then declined by 3.7% to $963000.0 in 2025, then tumbled by 39.25% to $585000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $585000.0 (Q1 2026), $963000.0 (Q4 2025), and $962000.0 (Q1 2025), per Business Quant data.